Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-14 Purchase | 2023-08-16 4:31 pm | PRECIGEN INC. | PGEN | Hassan Fred Director | 570,345 | $1.75 | $998,104 | 878,942 (Direct) | View |
| 2021-12-29 Purchase | 2022-01-03 7:50 pm | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 19,300 | $14.17 | $273,390 | 19,300 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-09 Option Award | 2024-10-11 4:05 pm | N/A N/A | Cocrystal Pharma Inc. | COCP | Hassan Fred Director | 8,067 | $0 | 1,023,296 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 4:02 pm | N/A 2034-09-03 | EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:39 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-18 6:20 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 44,055 | $1.43 | 1,218,872 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-18 6:20 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 189,038 | $0 | 1,218,872 (Direct) | View |
| 2024-03-09 Exercise | 2024-03-12 7:53 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 106,837 | $0 | 985,779 (Direct) | View |
| 2023-07-18 Option Award | 2023-07-20 4:05 pm | N/A 2033-07-18 | Cocrystal Pharma Inc. | COCP | Hassan Fred Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:19 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-05-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 63,677 | $0 | 0 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:39 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 2,123 | $0 | 2,123 (Direct) | View |
Ownership | 2023-04-27 4:01 pm | N/A N/A | Cocrystal Pharma Inc. | COCP | Hassan Fred Director | 0 | $0 | 1,015,229 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 5:02 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 48,290 | $1.17 | 540,923 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 5:02 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 232,326 | $0 | 540,923 (Direct) | View |
| 2023-02-22 Exercise | 2023-02-24 8:09 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 61,576 | $0 | 260,307 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:29 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 104,921 | $0 | 104,921 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:20 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 21,013 | $0 | 21,013 (Direct) | View |
| 2022-03-25 Exercise | 2022-03-29 5:04 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 16,212 | $0 | 198,731 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 5:48 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 144,765 | $0 | 327,284 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 5:48 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 27,832 | $2.03 | 327,284 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:19 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 541 | $0 | 541 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-26 5:14 pm | N/A 2031-08-16 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 49,869 | $0 | 49,869 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-17 7:24 pm | N/A 2031-05-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 7:46 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 38,319 | $0 | 193,006 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 7:46 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 7,328 | $7.71 | 193,006 (Direct) | View |
| 2021-03-13 Exercise | 2021-03-16 4:35 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 62,189 | $0 | 147,359 (Direct) | View |
| 2020-05-05 Option Award | 2020-05-07 8:40 pm | N/A N/A | AMGEN INC | AMGN | Hassan Fred Director | 846 | $0 | 9,191 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 6:32 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 158,513 | $0 | 243,683 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 6:32 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 28,109 | $2.01 | 243,683 (Direct) | View |
| 2020-03-08 Exercise | 2020-03-10 4:18 pm | N/A N/A | PRECIGEN INC. | PGEN | Hassan Fred Director | 24,703 | $0 | 57,061 (Direct) | View |